Back to Deutsche Bank AG Deutsche Bank AG

SMMT

Showing 8 of 19 quarters

Position history for Deutsche Bank AGDeutsche Bank AG's holdings in Summit Therapeutics Inc.

Yes. Deutsche Bank holds 239,347 shares of SMMT (Summit Therapeutics), worth $3.5M, as of its Q2 2026 13F filing. It increased the position by 1,559 shares (+0.7%) from Q1 2026. Deutsche Bank has held SMMT since Q2 2023, across 13 quarterly 13F filings.

Current Value

$3.5M

Current Shares

239,347

Total Value Change

-$5.2M

Total Shares Change

-158,331

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
239,347
+0.7%
$3.5M0.0%$14.57
27
2026-Q1
Unchanged
237,788
0.0%
$4.5M0.0%$18.96
0
2025-Q4
Decreased
237,788
-11.9%
$4.2M0.0%$17.49
0
2025-Q3
Increased
269,884
+0.8%
$5.6M0.0%$20.66
27
2025-Q2
Decreased
267,788
-37.4%
$5.7M0.0%$21.28
0
2025-Q1
Decreased
427,619
-10.7%
$8.2M0.0%$19.29
0
2024-Q4
Increased
478,808
+20.4%
$8.5M0.0%$17.85
33
2024-Q3
Increased
397,678
+733.8%
$8.7M0.0%$20.89
44

Other major holders of SMMT: Baker Bros. Advisors LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used